✦ LIBER ✦

Prevalence of HIV, hepatitis B and hepatitis C and associated risk behaviours amongst injecting drug users in three Afghan cities

✍ Scribed by Abdul Nasir; Catherine S. Todd; M. Raza Stanekzai; Christian T. Bautista; Boulos A. Botros; Paul T. Scott; Steffanie A. Strathdee; Jeffrey Tjaden

Book ID: 113570054
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 189 KB
Volume: 22
Category: Article
ISSN: 0955-3959
DOI: 10.1016/j.drugpo.2010.10.006

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The Australian Study of HIV and Injectin

The Australian Study of HIV and Injecting Drug Use. Part I: Prevalence for HIV, hepatitis B and hepatitis C among injecting drug users in four Australian cities

✍ Dr WENDY M. LOXLEY; MIKE PHILLIPS; SUSAN J. CARRUTHERS; JUDE S. BEVAN 📂 Article 📅 1997 🏛 Informa plc 🌐 English ⚖ 678 KB

Demographic, risk behaviour and personal

Demographic, risk behaviour and personal network variables associated with prevalent hepatitis C, hepatitis B, and HIV infection in injection drug users in Winnipeg, Canada

✍ John L Wylie; Lena Shah; Ann M Jolly 📂 Article 📅 2006 🏛 BioMed Central 🌐 English ⚖ 302 KB

Risk behaviors and HIV, hepatitis B, and

Risk behaviors and HIV, hepatitis B, and hepatitis C seroprevalence among injection drug users in Georgia

✍ Ekaterine Shapatava; Kenrad E. Nelson; Tengiz Tsertsvadze; Carlos del Rio 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 447 KB

Prevalence of hepatitis B virus and risk

Prevalence of hepatitis B virus and risk factors in Brazilian non-injecting drug users

✍ Renata C. Ferreira; Fabiana P. Rodrigues; Sheila A. Teles; Carmen L.R. Lopes; An 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB 👁 2 views

## Abstract Non‐injecting drug users are at high‐risk for acquiring hepatitis B virus (HBV), although the factors contributing to this increased risk are not known. In the present study, the overall and occult HBV infection prevalence rates were determined in a large population of non‐injecting dru

A hepatitis A, B, C and HIV prevalence a

A hepatitis A, B, C and HIV prevalence and risk factor study in ever injecting and non-injecting drug users in Luxembourg associated with HAV and HBV immunisations

✍ Nathalie Removille; Alain Origer; Sophie Couffignal; Michel Vaillant; Jean-Claud 📂 Article 📅 2011 🏛 BioMed Central 🌐 English ⚖ 374 KB

Risk behaviors and antibody hepatitis B

Risk behaviors and antibody hepatitis B and C prevalence among injecting drug users in south-western Sydney, Australia

✍ LISA MAHER; KERRY CHANT; BIN JALALUDIN; PENNY SARGENT 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB